Watch for Additive CNS Effects With Diabetic Peripheral Neuropathy Meds

September 2017

Patients will need your help managing painful diabetic neuropathy.

A hospitalization is a good time to reassess treatment options...and help patients set realistic expectations for pain relief.

Educate that meds will lead to a 30% to 50% decrease in symptoms in most patients. And most meds have limited evidence.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
300+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Learn More

Already a subscriber? Log in

Not sold to individuals

Table of Contents

Parkinson's Disease Avoid Adjusting Parkinson's Med Regimens When Patients are Hospitalized
Antiplatelets Lean Toward Tirofiban or Eptifibatide When Bridging During DAPT Interruption
Med Safety Compound Oral Liquid Meds Using New National Standard Concentrations
Anticoagulants Don't Jump to DOACs First-Line for Cancer-Related VTE
Dermatology Know How to Handle MRIs, Med Administration, and Cellulitis With Tattoos
Hypertension Watch for Commonly Used Meds That May Increase Blood Pressure
Liver Disease Optimize Meds for Comorbidities in Nonalcoholic Fatty Liver Disease
Neurology & Pain Watch for Additive CNS Effects With Diabetic Peripheral Neuropathy Meds
Cannabinoids Be Familiar With Acute Marijuana Toxicity...and How to Treat It
Multiple Sclerosis Help Safely Transition Patients Receiving Multiple Sclerosis Meds at Home
Storage & Disposal Don't Break the Cold Chain With Refrigerated and Frozen Meds
New Drugs Feel Comfortable Holding the Postmenopausal Med Intrarosa on Admission